Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 344

1.

Antimalarial myopathy in a systemic lupus erythematosus patient with quadriparesis and seizures: a case-based review.

Jafri K, Zahed H, Wysham KD, Patterson S, Nolan AL, Bucknor MD, Chaganti RK.

Clin Rheumatol. 2017 Jun;36(6):1437-1444. doi: 10.1007/s10067-017-3579-8. Epub 2017 Feb 24. Review.

PMID:
28236156
2.

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.

Bagrodia A, Lee BH, Lee W, Cha EK, Sfakianos JP, Iyer G, Pietzak EJ, Gao SP, Zabor EC, Ostrovnaya I, Kaffenberger SD, Syed A, Arcila ME, Chaganti RS, Kundra R, Eng J, Hreiki J, Vacic V, Arora K, Oschwald DM, Berger MF, Bajorin DF, Bains MS, Schultz N, Reuter VE, Sheinfeld J, Bosl GJ, Al-Ahmadie HA, Solit DB, Feldman DR.

J Clin Oncol. 2016 Nov 20;34(33):4000-4007. doi: 10.1200/JCO.2016.68.7798. Epub 2016 Sep 30.

3.

Mechanism and Role of SOX2 Repression in Seminoma: Relevance to Human Germline Specification.

Kushwaha R, Jagadish N, Kustagi M, Mendiratta G, Seandel M, Soni R, Korkola JE, Thodima V, Califano A, Bosl GJ, Chaganti RSK.

Stem Cell Reports. 2016 May 10;6(5):772-783. doi: 10.1016/j.stemcr.2016.04.002. Epub 2016 Apr 28.

4.

Development and Validation of a Gene-Based Model for Outcome Prediction in Germ Cell Tumors Using a Combined Genomic and Expression Profiling Approach.

Korkola JE, Heck S, Olshen AB, Feldman DR, Reuter VE, Houldsworth J, Bosl GJ, Chaganti RS.

PLoS One. 2015 Dec 1;10(12):e0142846. doi: 10.1371/journal.pone.0142846. eCollection 2015.

5.

Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression.

Bisikirska B, Bansal M, Shen Y, Teruya-Feldstein J, Chaganti R, Califano A.

Cancer Res. 2016 Feb 1;76(3):664-74. doi: 10.1158/0008-5472.CAN-15-0828. Epub 2015 Nov 20.

6.

Cross-platform assessment of genomic imbalance confirms the clinical relevance of genomic complexity and reveals loci with potential pathogenic roles in diffuse large B-cell lymphoma.

Dias LM, Thodima V, Friedman J, Ma C, Guttapalli A, Mendiratta G, Siddiqi IN, Syrbu S, Chaganti RS, Houldsworth J.

Leuk Lymphoma. 2016;57(4):899-908. doi: 10.3109/10428194.2015.1080364. Epub 2015 Nov 16.

7.

Direct ChIP-Seq significance analysis improves target prediction.

Bansal M, Mendiratta G, Anand S, Kushwaha R, Kim R, Kustagi M, Iyer A, Chaganti RS, Califano A, Sumazin P.

BMC Genomics. 2015;16 Suppl 5:S4. doi: 10.1186/1471-2164-16-S5-S4. Epub 2015 May 26.

8.

Sweet heart: A case of pregnancy-associated acute febrile neutrophilic dermatosis with myopericarditis.

Yu WY, Manrriquez E, Bhutani T, Chaganti RK, Ruben BS, Schwartz BS, Fox LP.

JAAD Case Rep. 2014 Sep 30;1(1):12-4. doi: 10.1016/j.jdcr.2014.09.005. eCollection 2015 Jan. No abstract available.

9.

A genomic algorithm for the molecular classification of common renal cortical neoplasms: development and validation.

Gowrishankar B, Przybycin CG, Ma C, Nandula SV, Rini B, Campbell S, Klein E, Chaganti RS, Magi-Galluzzi C, Houldsworth J.

J Urol. 2015 May;193(5):1479-85. doi: 10.1016/j.juro.2014.11.099. Epub 2014 Dec 11.

PMID:
25498568
10.

Interrogation of a context-specific transcription factor network identifies novel regulators of pluripotency.

Kushwaha R, Jagadish N, Kustagi M, Tomishima MJ, Mendiratta G, Bansal M, Kim HR, Sumazin P, Alvarez MJ, Lefebvre C, Villagrasa-Gonzalez P, Viale A, Korkola JE, Houldsworth J, Feldman DR, Bosl GJ, Califano A, Chaganti RS.

Stem Cells. 2015 Feb;33(2):367-77. doi: 10.1002/stem.1870.

11.

Response to Letter to the Editor: "Food frequency questionnaire is an effective method for measuring micronutrient intake.".

Chaganti RK, Lane NE, Nevitt MC.

Osteoarthritis Cartilage. 2014 Nov;22(11):1949-50. doi: 10.1016/j.joca.2014.08.007. Epub 2014 Aug 26. No abstract available.

12.

Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy.

Oricchio E, Ciriello G, Jiang M, Boice MH, Schatz JH, Heguy A, Viale A, de Stanchina E, Teruya-Feldstein J, Bouska A, McKeithan T, Sander C, Tam W, Seshan VE, Chan WC, Chaganti RS, Wendel HG.

J Exp Med. 2014 Jun 30;211(7):1379-91. doi: 10.1084/jem.20132120. Epub 2014 Jun 9.

13.

Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors.

Feldman DR, Iyer G, Van Alstine L, Patil S, Al-Ahmadie H, Reuter VE, Bosl GJ, Chaganti RS, Solit DB.

Clin Cancer Res. 2014 Jul 15;20(14):3712-20. doi: 10.1158/1078-0432.CCR-13-2868. Epub 2014 May 8.

14.

Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization.

Gowrishankar B, Cahill L, Arndt AE, Al-Ahmadie H, Lin O, Chadalavada K, Chaganti S, Nanjangud GJ, Murty VV, Chaganti RS, Reuter VE, Houldsworth J.

BJU Int. 2014 Dec;114(6):881-90. doi: 10.1111/bju.12643. Epub 2014 Jul 15.

15.

miR-18b and miR-518b Target FOXN1 during epithelial lineage differentiation in pluripotent cells.

Kushwaha R, Thodima V, Tomishima MJ, Bosl GJ, Chaganti RS.

Stem Cells Dev. 2014 May 15;23(10):1149-56. doi: 10.1089/scd.2013.0262. Epub 2014 Mar 21.

PMID:
24383669
16.

Elevation of serum tumor necrosis factor α in patients with periprosthetic osteolysis: a case-control study.

Chaganti RK, Purdue E, Sculco TP, Mandl LA.

Clin Orthop Relat Res. 2014 Feb;472(2):584-9. doi: 10.1007/s11999-013-3235-9.

17.

High plasma levels of vitamin C and E are associated with incident radiographic knee osteoarthritis.

Chaganti RK, Tolstykh I, Javaid MK, Neogi T, Torner J, Curtis J, Jacques P, Felson D, Lane NE, Nevitt MC; Multicenter Osteoarthritis Study Group (MOST).

Osteoarthritis Cartilage. 2014 Feb;22(2):190-6. doi: 10.1016/j.joca.2013.11.008. Epub 2013 Nov 28.

18.

Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia.

Houldsworth J, Guttapalli A, Thodima V, Yan XJ, Mendiratta G, Zielonka T, Nanjangud G, Chen W, Patil S, Mato A, Brown JR, Rai K, Chiorazzi N, Chaganti RS.

Leuk Lymphoma. 2014 Apr;55(4):920-8. doi: 10.3109/10428194.2013.845882. Epub 2013 Nov 12.

19.

Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins.

Costa-Guda J, Imanishi Y, Palanisamy N, Kawamata N, Phillip Koeffler H, Chaganti RS, Arnold A.

Endocrine. 2013 Oct;44(2):489-95. doi: 10.1007/s12020-013-9903-4. Epub 2013 Feb 24.

20.

Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition.

Cavallo F, Graziani G, Antinozzi C, Feldman DR, Houldsworth J, Bosl GJ, Chaganti RS, Moynahan ME, Jasin M, Barchi M.

PLoS One. 2012;7(12):e51563. doi: 10.1371/journal.pone.0051563. Epub 2012 Dec 12.

21.

Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression.

López-Lago MA, Posner S, Thodima VJ, Molina AM, Motzer RJ, Chaganti RS.

Oncogene. 2013 Apr 4;32(14):1752-60. doi: 10.1038/onc.2012.201. Epub 2012 Jun 4.

22.

The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma.

Oricchio E, Nanjangud G, Wolfe AL, Schatz JH, Mavrakis KJ, Jiang M, Liu X, Bruno J, Heguy A, Olshen AB, Socci ND, Teruya-Feldstein J, Weis-Garcia F, Tam W, Shaknovich R, Melnick A, Himanen JP, Chaganti RS, Wendel HG.

Cell. 2011 Oct 28;147(3):554-64. doi: 10.1016/j.cell.2011.09.035.

23.

Risk factors for incident osteoarthritis of the hip and knee.

Chaganti RK, Lane NE.

Curr Rev Musculoskelet Med. 2011 Sep;4(3):99-104. doi: 10.1007/s12178-011-9088-5.

24.

NT5E mutations and arterial calcifications.

St Hilaire C, Ziegler SG, Markello TC, Brusco A, Groden C, Gill F, Carlson-Donohoe H, Lederman RJ, Chen MY, Yang D, Siegenthaler MP, Arduino C, Mancini C, Freudenthal B, Stanescu HC, Zdebik AA, Chaganti RK, Nussbaum RL, Kleta R, Gahl WA, Boehm M.

N Engl J Med. 2011 Feb 3;364(5):432-42. doi: 10.1056/NEJMoa0912923.

25.

Genomic deregulation during metastasis of renal cell carcinoma implements a myofibroblast-like program of gene expression.

López-Lago MA, Thodima VJ, Guttapalli A, Chan T, Heguy A, Molina AM, Reuter VE, Motzer RJ, Chaganti RS.

Cancer Res. 2010 Dec 1;70(23):9682-92. doi: 10.1158/0008-5472.CAN-10-2279. Epub 2010 Oct 15.

26.

Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: the osteoporotic fractures in men study.

Chaganti RK, Parimi N, Cawthon P, Dam TL, Nevitt MC, Lane NE.

Arthritis Rheum. 2010 Feb;62(2):511-4. doi: 10.1002/art.27241.

27.

Bone mineral density and prevalent osteoarthritis of the hip in older men for the Osteoporotic Fractures in Men (MrOS) Study Group.

Chaganti RK, Parimi N, Lang T, Orwoll E, Stefanick ML, Nevitt M, Lane NE; Osteoporotic Fractures in Men (MrOS) Study Group.

Osteoporos Int. 2010 Aug;21(8):1307-16. doi: 10.1007/s00198-009-1105-9. Epub 2010 Jan 26.

28.

Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin.

Korkola JE, Houldsworth J, Bosl GJ, Chaganti RS.

BJU Int. 2009 Nov;104(9 Pt B):1334-8. doi: 10.1111/j.1464-410X.2009.08855.x. Review.

29.

Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors.

Korkola JE, Houldsworth J, Feldman DR, Olshen AB, Qin LX, Patil S, Reuter VE, Bosl GJ, Chaganti RS.

J Clin Oncol. 2009 Nov 1;27(31):5240-7. doi: 10.1200/JCO.2008.20.0386. Epub 2009 Sep 21.

30.

Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.

Jagu S, Karanam B, Gambhira R, Chivukula SV, Chaganti RJ, Lowy DR, Schiller JT, Roden RB.

J Natl Cancer Inst. 2009 Jun 3;101(11):782-92. doi: 10.1093/jnci/djp106. Epub 2009 May 26.

31.

The association of proximal femoral shape and incident radiographic hip OA in elderly women.

Lynch JA, Parimi N, Chaganti RK, Nevitt MC, Lane NE; Study of Osteoporotic Fractures Research Group.

Osteoarthritis Cartilage. 2009 Oct;17(10):1313-8. doi: 10.1016/j.joca.2009.04.011. Epub 2009 Apr 23.

32.

Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.

Gopalan A, Dhall D, Olgac S, Fine SW, Korkola JE, Houldsworth J, Chaganti RS, Bosl GJ, Reuter VE, Tickoo SK.

Mod Pathol. 2009 Aug;22(8):1066-74. doi: 10.1038/modpathol.2009.66. Epub 2009 Apr 24.

33.

Pathway activation in large B-cell non-Hodgkin lymphoma cell lines by doxorubicin reveals prognostic markers of in vivo response.

Houldsworth J, Petlakh M, Olshen AB, Chaganti RS.

Leuk Lymphoma. 2008 Nov;49(11):2170-80. doi: 10.1080/10428190802428369.

PMID:
19021061
34.

Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.

Nanjangud G, Rao PH, Teruya-Feldstein J, Donnelly G, Qin J, Mehra S, Jhanwar SC, Zelenetz AD, Chaganti RS.

Cytogenet Genome Res. 2007;118(2-4):337-44.

PMID:
18000388
35.

Change in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis.

Chaganti RK, Kelman A, Lui L, Yao W, Javaid MK, Bauer D, Nevitt M, Lane NE; Study Of Osteoporotic Fractures Research Group Sof.

Osteoarthritis Cartilage. 2008 May;16(5):566-71. Epub 2007 Oct 22.

36.

In vivo differentiation and genomic evolution in adult male germ cell tumors.

Korkola JE, Heck S, Olshen AB, Reuter VE, Bosl GJ, Houldsworth J, Chaganti RS.

Genes Chromosomes Cancer. 2008 Jan;47(1):43-55.

PMID:
17943972
37.

Interferon-alpha resistance associated genes in renal cell carcinoma identified by expression profiling.

Korkola JE, Kondagunta GV, Reuter VE, Motzer RJ, Chaganti RS.

J Urol. 2007 Apr;177(4):1264-8; discussion 1268.

PMID:
17382702
38.

Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes.

Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, Dürst M, Schneider A, Pothuri B, Mansukhani M, Basso K, Chaganti RS, Murty VV.

Genes Chromosomes Cancer. 2007 Apr;46(4):373-84.

PMID:
17243165
39.

Targeting von Hippel-Lindau pathway in renal cell carcinoma.

Patel PH, Chadalavada RS, Chaganti RS, Motzer RJ.

Clin Cancer Res. 2006 Dec 15;12(24):7215-20. Review.

40.

Biology and genetics of adult male germ cell tumors.

Houldsworth J, Korkola JE, Bosl GJ, Chaganti RS.

J Clin Oncol. 2006 Dec 10;24(35):5512-8.

PMID:
17158536
41.

Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells.

Chadalavada RS, Korkola JE, Houldsworth J, Olshen AB, Bosl GJ, Studer L, Chaganti RS.

Stem Cells. 2007 Mar;25(3):771-8. Epub 2006 Nov 30.

42.

Macular star associated with Behçet disease.

Chan RV, Lee TC, Chaganti RK, Cestari DM, Kim MT, Lee S.

Retina. 2006 Apr;26(4):468-70. No abstract available.

PMID:
16603968
43.

Transcriptional program associated with IFN-alpha response of renal cell carcinoma.

Banerjee D, Chadalavada RS, Bourdon V, Korkola JE, Motzer RJ, Chaganti RS.

J Interferon Cytokine Res. 2006 Mar;26(3):156-70.

PMID:
16542138
44.

Targeted therapy for metastatic renal cell carcinoma.

Patel PH, Chaganti RS, Motzer RJ.

Br J Cancer. 2006 Mar 13;94(5):614-9. Review.

45.

Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors.

Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE, Bosl GJ, Chaganti RS.

Cancer Res. 2006 Jan 15;66(2):820-7.

46.

Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas.

Chen W, Houldsworth J, Olshen AB, Nanjangud G, Chaganti S, Venkatraman ES, Halaas J, Teruya-Feldstein J, Zelenetz AD, Chaganti RS.

Blood. 2006 Mar 15;107(6):2477-85. Epub 2005 Nov 29.

47.

Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL.

Moskowitz CH, Zelenetz AD, Kewalramani T, Hamlin P, Lessac-Chenen S, Houldsworth J, Olshen A, Chaganti R, Nimer S, Teruya-Feldstein J.

Blood. 2005 Nov 15;106(10):3383-5. Epub 2005 Aug 9.

PMID:
16091454
48.

Gene expression-based classification of nonseminomatous male germ cell tumors.

Korkola JE, Houldsworth J, Dobrzynski D, Olshen AB, Reuter VE, Bosl GJ, Chaganti RS.

Oncogene. 2005 Jul 28;24(32):5101-7.

PMID:
15870693
49.

Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells.

Chadalavada RS, Houldsworth J, Olshen AB, Bosl GJ, Studer L, Chaganti RS.

Funct Integr Genomics. 2005 Apr;5(2):59-69. Epub 2005 Feb 3.

PMID:
15690164
50.

Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.

Xiao Q, Shen N, Hedvat CV, Moskowitz CH, Sussman LK, Filippa DA, Zelenetz AD, Houldsworth J, Chaganti RS, Teruya-Feldstein J.

Appl Immunohistochem Mol Morphol. 2004 Sep;12(3):211-5.

PMID:
15551733

Supplemental Content

Loading ...
Support Center